Survey of diagnostic and typing capacity for enterovirus infection in Italy and identification of two echovirus 30 outbreaks.


Journal

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
ISSN: 1873-5967
Titre abrégé: J Clin Virol
Pays: Netherlands
ID NLM: 9815671

Informations de publication

Date de publication:
04 2021
Historique:
received: 28 08 2020
revised: 12 02 2021
accepted: 14 02 2021
pubmed: 13 3 2021
medline: 18 9 2021
entrez: 12 3 2021
Statut: ppublish

Résumé

Enterovirus infections can cause a variety of illnesses, ranging from asymptomatic infections to severe illness and death. To support polio eradication activities, in February 2019, the WHO Regional Reference Laboratory for polio in Italy, at the National Institute of Public Health (Istituto Superiore di Sanità), promoted an investigation on non-polio enterovirus laboratory capacity, with the support of the Italian Ministry of Health. The aim was to collect data on the assays used routinely for diagnostic purposes and to characterize enterovirus outbreaks strains by sequence analysis of the Viral Protein 1 region. A questionnaire was administered to public health laboratories through all Italian Regions for 2018 and subsequently, an electronic form for lab-confirmed enterovirus infection reported from February 2019 to January 2020, including patients clinical characteristics, and laboratory data was distributed through 25 laboratories participating the survey. Overall, a homogenous laboratory capacity for enterovirus infection diagnosis was found and 21,000 diagnostic tests were retrospectively reported in 2018. Then, in 2019, two outbreaks of Echovirus 30 were identified and confirmed by molecular analyses. These results underline the need monitor the circulation of non-polio enterovirus to ascertain the real burden of the disease in the country.

Sections du résumé

BACKGROUND
Enterovirus infections can cause a variety of illnesses, ranging from asymptomatic infections to severe illness and death.
AIM
To support polio eradication activities, in February 2019, the WHO Regional Reference Laboratory for polio in Italy, at the National Institute of Public Health (Istituto Superiore di Sanità), promoted an investigation on non-polio enterovirus laboratory capacity, with the support of the Italian Ministry of Health. The aim was to collect data on the assays used routinely for diagnostic purposes and to characterize enterovirus outbreaks strains by sequence analysis of the Viral Protein 1 region.
METHODS
A questionnaire was administered to public health laboratories through all Italian Regions for 2018 and subsequently, an electronic form for lab-confirmed enterovirus infection reported from February 2019 to January 2020, including patients clinical characteristics, and laboratory data was distributed through 25 laboratories participating the survey.
RESULTS
Overall, a homogenous laboratory capacity for enterovirus infection diagnosis was found and 21,000 diagnostic tests were retrospectively reported in 2018. Then, in 2019, two outbreaks of Echovirus 30 were identified and confirmed by molecular analyses.
CONCLUSION
These results underline the need monitor the circulation of non-polio enterovirus to ascertain the real burden of the disease in the country.

Identifiants

pubmed: 33711692
pii: S1386-6532(21)00030-5
doi: 10.1016/j.jcv.2021.104763
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

104763

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier B.V. All rights reserved.

Auteurs

Stefano Fontana (S)

Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.

Daniela Cimini (D)

UOC ISP Prevention of Infectious and Chronic Diseases, Department of Prevention, Area Vasta 2 Fabriano, Regional Health Authority, Marche Region, Italy.

Katia Marinelli (K)

SOD Virologia Azienda Ospedaliero, Universitaria Ospedali Riuniti Umberto I°, Lancisi-Salesi, Ancona, Italy.

Giada Gori (G)

UOC ISP Prevention of Infectious and Chronic Diseases, Department of Prevention, Area Vasta 2 Fabriano, Regional Health Authority, Marche Region, Italy.

Vania Moroni (V)

UOC ISP Prevention of Infectious and Chronic Diseases, Department of Prevention, Area Vasta 2 Fabriano, Regional Health Authority, Marche Region, Italy.

Patrizia Bagnarelli (P)

SOD Virologia Azienda Ospedaliero, Universitaria Ospedali Riuniti Umberto I°, Lancisi-Salesi, Ancona, Italy.

Lucia Collini (L)

Microbiology and Virology Unit, Santa Chiara Hospital, APSS, Trento, Italy.

Elisabetta Pagani (E)

Laboratory of Microbiology and Virology, Comprensorio Sanitario di Bolzano, Bolzano, Italy.

Elisa Masi (E)

Laboratory of Microbiology and Virology, Comprensorio Sanitario di Bolzano, Bolzano, Italy.

Gabriele Buttinelli (G)

Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.

Stefano Fiore (S)

Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.

Concetta Amato (C)

Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.

Valter Carraro (V)

Department of Hygiene and Public Health, Azienda Autonoma Sanitaria della Provincia di Trento, Trento, Italy.

Paola Stefanelli (P)

Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy. Electronic address: paola.stefanelli@iss.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH